GRANTIBASE
RegisterSign in
  • Funding
  • Ecosystem
  • Finance
  • More

    • Organizations
    • Projects
    • Insights
    • Pricing
    • Create new initiative
    • Match from website

Grantibase.com — Decision support for funding strategy, discovery, and consortium execution.

© 2026 Grantibase. All rights reserved.·Terms and conditions·Privacy policy·Cookies·Support·Premium features·Pricing

GRANTIBASE

Funded projects

Explore funded EU projects and the organizations behind them — filter by programme, call, country, sector, and more. Results are from completed CORDIS grant records, not open calls; for live funding opportunities, visit Funding.

Filters2Filters2

Filters

Project

Full-text search across title, acronym, topics, keywords, summary, and objective.

Filter by how projects are classified in the dataset.

Matches the EuroSciVoc taxonomy linked to projects, not free-text project topics.

Canonical business sectors mapped from multilingual project signals.

Based on each project's start date.

EU contribution (€)

Based on estimated EU contribution value.

Search by CORDIS call code (free text) or by call identifier. This is different from live Funding & Tenders opportunities.

Matches project topic and keyword text, separate from EuroSciVoc classification.

Organization

At least one partner based in that country (CORDIS ISO code). Organization filters are combined with AND logic.

Matches legal name, short name, or organization ID among partners.

Only the organization with coordinator role in the consortium.

At least one partner with this ETL-normalized type.

Active filters

Sector: Health & BiotechCountry: ES

Results

Showing 25 of 5,740 matching projects.

ProjectEU contributionTotal cost
Human-Centric AI platform for heALth and Life sciences

Horizon EuropeHorizon EuropeClosed2023DKDK

HCAI4ALL · 190199127

€2,495,099
Total €3,564,428
€3,564,428Details
An AI-Powered Visual Assistive Design IoT Pathway Platform to implement fast and optimal automated patient pathways and healthcare demand planning projects

Horizon EuropeHorizon EuropeClosed2022ESES

PATHMAKER · 190198323

€1,810,550
Total €2,586,500
€2,586,500Details
Gate2Brain. Medicines beyond barriers.

Horizon EuropeHorizon EuropeSigned2023ESES

Gate2Brain · 190196379

€2,470,759
Total €3,529,656
€3,529,656Details
Translational Microbiome Platform

Horizon EuropeHorizon EuropeClosed2022ESES

MICK · 190195702

€2,156,682
Total €3,080,974
€3,080,974Details
Revolutionising the diagnosis of multiple Sclerosis with the first bioinformatic diagnostic kit that allows early detection with a simple blood test

Horizon EuropeHorizon EuropeSigned2023ESES

ALA DIAGNOSTICS MS KIT · 190194105

€1,407,525
Total €2,010,750
€2,010,750Details
Sonophoresis smartpatch for pain-free, controllable, and wearable transdermal drug delivery

Horizon EuropeHorizon EuropeSigned2023ESES

SONOPHORESIS SMARTPATCH · 190189473

€2,499,999
Total €3,840,375
€3,840,375Details
TUCUVI Voice and Artificial Intelligence to reduce the impact of chronic diseases

Horizon EuropeHorizon EuropeSigned2023ESES

TUCUVI · 190184468

€2,500,000
Total €3,634,848
€3,634,848Details
First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1)

Horizon EuropeHorizon EuropeSigned2023ESES

fight-dm1 · 190181217

€2,500,000
Total €20,074,283
€20,074,283Details
Disruptive and high accuracy test for early colorectal cancer detection in blood

Horizon EuropeHorizon EuropeClosed2022ESES

PreveCol · 190177779

€2,497,568
Total €3,567,955
€3,567,955Details
Diagnosis of large vessel occlusion (LVO) in acute stroke for improving access to treatment

Horizon EuropeHorizon EuropeClosed2023ESES

LVOCheck · 190176251

€2,772,276
Total €3,960,395
€3,960,395Details
WILLEM: AI to Reduce Cardiovascular Diseases

Horizon EuropeHorizon EuropeClosed2022ESES

WILLEM: AI to Reduce Cardiovascular Diseases · 190173745

€2,500,000
Total €3,596,296
€3,596,296Details
The first medical device for non-invasive detection and monitoring of infant meningitis

Horizon EuropeHorizon EuropeSigned2022ESES

NEOSONICS · 190155553

€2,500,000
Total €4,125,059
€4,125,059Details
Smart Ultraviolet Radiation Filters

Horizon EuropeHorizon EuropeClosed2022ESES

SMART UV · 190153981

€1,728,011
Total €2,474,838
€2,474,838Details
Reshaping women's health through the understanding of gynecological fluids. WomEC: Antibody-based IVD test based on 5 novel protein biomarkers quantified in liquid biopsy

Horizon EuropeHorizon EuropeSigned2023ESES

WomEC · 190153073

€2,499,999
Total €3,853,213
€3,853,213Details
Development of the first oral disease-modifying treatment for chronic obstructive pulmonary disease (COPD)

Horizon EuropeHorizon EuropeClosed2022ESES

RESPIRE · 190151672

€2,476,107
Total €3,537,295
€3,537,295Details
Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour cases

Horizon EuropeHorizon EuropeSigned2023ESES

FineBirth · 190144075

€2,342,836
Total €3,346,908
€3,346,908Details
Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseases

Horizon EuropeHorizon EuropeSigned2023ESES

EGNITE · 190141476

€2,493,750
Total €3,562,500
€3,562,500Details
Paradigm shift in stroke: accurate diagnosis and evaluation of all treatment options in any hospital, at any time

Horizon EuropeHorizon EuropeClosed2023ESES

Deepstroke-Acc · 190136266

€2,495,415
Total €3,564,879
€3,564,879Details
ELEM Virtual Heart Populations for Supercomputers

Horizon EuropeHorizon EuropeSigned2023ESES

ELVIS · 190134524

€2,482,097
Total €3,545,853
€3,545,853Details
Revolutionizing remote care of chronic disease patients – an interoperable and smart monitoring platform

Horizon EuropeHorizon EuropeSigned2022ESES

HumanITcare · 190127290

€2,438,800
Total €3,592,250
€3,592,250Details
BraiN20®: A paradigm shift in Acute Ischemic Stroke (AIS) patient management

Horizon EuropeHorizon EuropeSigned2023ESES

promise · 190126352

€2,500,000
Total €5,150,878
€5,150,878Details
VISUALIZACIÓN DE BIOPOTENCIALES PARA EQUIPOS CARDIOLÓGICOS

Horizon EuropeHorizon EuropeSigned2022ESES

VR-CARDIO · 190123244

€2,499,999
Total €3,589,741
€3,589,741Details
Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis Complex

Horizon EuropeHorizon EuropeSigned2023ESES

oils4cure · 190119321

€1,557,877
Total €2,225,539
€2,225,539Details
Gold Radiosensitizers for Advanced Proton therapy

Horizon EuropeHorizon EuropeSigned2026ESES

GRAPE · 101292396

€150,000
Total —
—Details
Cellular Analysis with Multi-Sample MRI Platform

Horizon EuropeHorizon EuropeSigned2026ESES

CAMP · 101291716

€150,000
Total —
—Details